Quick Answer
United Health Products, Inc. reported R&D Expense of $355.9 thousand for fiscal year 2024.
United Health Products, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $355.9K | -40.6% |
| 2023 | $598.8K | -4.1% |
| 2022 | $624.6K | +163.0% |
| 2021 | $237.5K | -3.2% |
| 2020 | $245.2K | -63.2% |
| 2019 | $666.4K | +766.0% |
| 2018 | $77.0K | +286.0% |
| 2017 | $19.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.3K | -61.5% | -68.7% |
| June 30, 2025 | $81.0K | +23.2% | -30.3% |
| March 31, 2025 | $116.3K | +0.6% | +76.4% |
| September 30, 2024 | $65.9K | -45.9% | +0.3% |
| June 30, 2024 | $65.7K | -37.5% | -43.1% |
| March 31, 2024 | $115.6K | -47.2% | -5.1% |
| September 30, 2023 | $121.8K | -43.4% | +15.8% |
| June 30, 2023 | $105.1K | -28.8% | -51.9% |
- United Health Products, Inc. showed a decrease of -40.6% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2024 period, United Health Products, Inc.’s r&d expense has grown by 1685.4% (from $19.9 thousand to $355.9 thousand).
- The most recent figure is from United Health Products, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: